Diabetes mellitus type 1 future or investigational therapies

Diabetes mellitus type 1 Microchapters
Home
patient information
Overview
Pathophysiology
Causes
Differentiating Diabetes mellitus type 1 from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural history, Complications, and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Other Diagnostic Studies
Treatment
Dietary Management
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Tertiary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1

Diabetes mellitus Microchapters
Home
Patient information
Diabetes Mellitus Type 1
Diabetes Mellitus Type 2
Gestational Diabetes
Overview
Historical Perspective
Classification Pre-Diabetics Impaired Fasting Glycaemia Impaired Glucose Tolerance Diabetics Type 1 Diabetes Type 2 Diabetes Gestational Diabetes Mellitus Other Causes
Pathophysiology
Causes
Epidemiology and Demographics
Differentiating Diabetes Mellitus from other Diseases
Risk Factors
Screening
Natural History, Complications, and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Other Diagnostic Studies
Treatment
Dietary Management
Medical Therapy
Diabetes with Hypertension Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Tertiary Prevention
Social Issues
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Diabetes mellitus type 1 future or investigational therapies On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Diabetes mellitus type 1 future or investigational therapies All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Diabetes mellitus type 1 future or investigational therapies
CDC on Diabetes mellitus type 1 future or investigational therapies
Diabetes mellitus type 1 future or investigational therapies in the news
Blogs on Diabetes mellitus type 1 future or investigational therapies</small>
Directions to Hospitals Treating Diabetes mellitus
Risk calculators and risk factors for Diabetes mellitus type 1 future or investigational therapies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Priyamvada Singh, M.B.B.S. [2]; Cafer Zorkun, M.D., Ph.D. [3]

Future or Investigational Therapies

Entities Involved in Research

This section is a complete list of mainly commercial companies but also other entities, namely governmental institutions and individual persons, actively involved in research towards finding a cure to diabetes type 1.
It does not list research funds, hospitals in which research is undertaken, etc., but only the industrious, actual developers of such products.

Entities are listed along with their status of research in that field, so that also entities which ceased research into finding a cure to diabetes type 1 may be listed.

Entities are alphabetically listed.

• Cerco Medical [4] – Present status: Unknown
• Denise Faustman [5] – Present status: Working on immune modification
• DeveloGen [6] – Present status: Developing DiaPep 277
• Diamyd Medical [7] – Present status: Developing GAD65-based vaccine (phase III application submitted to the FDA)
• Encelle [8] – Present status: On hold; awaiting decision on whether to move forward into encapsulated beta cell transplantation.